Blepharochalasis

Blepharochalasis is a rare disorder that typically affects upper lids. It is characterised by intermittent oedema of the lids, with frequent recurrence. It produces eyelid tissue relaxation and latter atrophy. It may be unilateral in some cases. In addition to recurrent attacks of oedema, it is associated with ‘cigarette-paper’ skin and subcutaneous telangiectasia.

The term blepharochalasis was coined by Fuchs in1896. The term blepharochalasis is frequently misused to indicate redundant skin of the ageing eyelid, a common condition more accurately termed as dermatochalasis.

The word blepharochalasis originates from the Greek word blepharon meaning eyelid and chalasis meaning relaxing.

References

Biswas Arnab. Ptosis Surgery. Jaypee Brothers Medical Publishers (P) Ltd 2010. P 102.

Basak Samar K. Atlas of Clinical Ophthalmology Second edition. Jaypee Brothers Medical Publishers (P) Ltd 2013. P 26.

Roy Frederick Hampton, Fraunfelder Frederick W, Fraunfelder Frederick T, Tindall Renee, Jensvold Bree. Roy and Fraunfelder’s Current Ocular Therapy Sixth Edition. Saunders Elsevier 2008. P 433.

Dutton Jonathan J, Gayre Gregg S, Proia Alan D. Diagnostic Atlas of Common Eyelid Diseases. Taylor & Francis Group, an Informa business 2007. P 57- 58.

Blodi FC, Mackensen G, Neubauer H. Surgical Ophthalmology 1. Springer- Verlag Berlin Heidelberg 1991. P 92- 93.

Ostler H Bruce, Maibach Howard I, Hoke Axel W, Schwab Ivan R. Diseases of the eye & Skin- A Color Atlas. Lippincott Williams & Wilkins 2004. P 100.

Stein Harold A, Stein Raymond M, Freeman Melvin I. The Ophthalmic Assistant- A Text for Allied and Associated Ophthalmic Personnel Ninth Edition. Elsevier Saunders 2013. P 406.

Bowling Brad, Kanski's Clinical Ophthalmology- A Systematic Approach. Eighth Edition. Elsevier, 2016. P 55.

Kanski Jack J, Bowling Brad. Clinical Ophthalmology- A Systematic Approach Seventh Edition. Elsevier Saunders 2011.

Yanoff Myron, Sassani Joseph W. Ocular Pathology Seventh Edition. Elsevier Saunders 2015. P 155.

Denniston Alastair KO, Murray Philip I. Oxford Handbook of Ophthalmology Third Edition. Oxford University Press 2014. P 161.

http://emedicine.medscape.com/article/1214014-overview

http://eyewiki.aao.org/Blepharochalasis_Syndrome

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1043545/pdf/brjopthal00212-0013.pdf

Fuchs E. Über Blepharochalasis (Erschlaffung der Lidhaut). Wien Klin Wschr 1896; 9: 109- 110.

Patient may present with symptoms like

  • Unilateral or bilateral transient painless swelling of the eyelids.
  • Unilateral or bilateral swelling of the conjunctiva.
  • Proptosis (bulging of the eyeball).
  • Prolapse of lacrimal gland.
  • Presence of pads of fat due to atrophy of the orbital septum and skin.
  • Deep superior sulcus due to fat atrophy.
  • Thin atrophic bronze coloured eyelid skin which resembles parchment (thin, flat and stiff) due to atrophy of fat.
  • Multiple fine telangiectatic vessels.
  • Blepharoptosis (drooping of eyelid) due to thinning and atrophy of aponeurosis of levator palpebrae superioris muscle.
  • Horizontal blepharophimosis and rounding of lateral canthus due to dehiscence of lateral canthal tendon.
  • Ectropion.
  • Pseudoepicanthal folds.

Eyelid changes are exacerbated by normal process of ageing.

Occasionally, attacks are aggravated by a triggering event such as fever, weeping, upper respiratory tract infection.

Blepharophimosis may be a form of chronic angioedema with localised vascular dilatation and extravasation of proteinaceous fluid. Orbital fat may have increased vascularity and dilated capillaries.  

Triggers:

Multiple triggers may be the factors including

  • Immune reactions.
  • Environmental factors.

Pathogenesis

Pathogenesis is uncertain, but this condition may be immunogenic in origin. There is abundance of IgA deposits around elastin fibers. Infrequently there may be familial occurrence (autosomal dominant inheritance).

Associations

Sometimes blepharochalasis is associated with systemic illnesses such as

  • Amyloidosis.
  • Dermatomyositis.
  • Leukaemia.
  • Laffer-Ascher syndrome showing oedema of lips and thyroid enlargement.
  • Melkersson-Rosenthal syndrome (triad of recurrent labial oedema, relapsing facial paralysis and fissured tongue) may present with eyelid oedema of unknown cause.

Rarely, blepharochalasis may be associated with agenesis of the kidney, vertebral abnormalities, and congenital heart defects.

Pathology

Pathology typically shows loss of elastic fibers, Lymphoedema, vasculitis and epithelial atrophy. Stretching of the aponeurotic fibers of levator palpebrae superioris muscle due to recurrent low grade inflammation produces aponeurotic ptosis (drooping) of the lids.

Diagnosis depends upon history of disease and clinical examination. There are no characteristic laboratory findings.

I. History:

Patient gives history of repeated episodes of painless swelling of one or both eyelids with subsequent thinning of skin, usually affecting people between the ages of 10-20 years. Oedema is initially seen frequently in upper lids. The frequency of attacks is variable. It may be associated with a preceding period of physical or emotional stress. Occasionally, there may be history of allergy.

II. Clinical features:

Patient shows clinical features such as lid or conjunctival oedema, proptosis, ptosis, telangiectasia of vessels, ectropion, entropion, skin parchment, or pseudoepicanthal folds. The skin hangs down over the upper eyelid.

The disease may be separated into

A. Early phase

It may be further divided as

  • Hypertrophic form.
  • Atrophic form.

B. Late phase.

 

Differential diagnosis

  • Angioedema: Usually older age of onset. Oedema is widespread and is not limited to the upper lid. There is an association with complement 1-esterase inhibitor deficiency and auto-antibodies.
  • Dermatochalasis: It is a common ageing process with redundant skin and fat prolapse.
  • Floppy eyelid syndrome: It is typically found in older, obese men. There is an association with papillary conjunctivitis.
  • Idiopathic lymphoedema: There is unremitting brawny oedema (swelling of subcutaneous tissue that cannot be indented easily), seen usually in older patients.
  • Tumour: It presents as progressively enlarging mass. Biopsy may be needed for the diagnosis.
  • Drug induced urticaria.

 

Nothing much can be done to ameliorate acute phase of blepharochalasis. Avoidance of triggering factors may diminish the frequency of attacks.

Medical therapy:

Supportive medical therapy may be provided in acute and active phase of the disease.

No pharmacologic agents have proven benefits in the treatment of blepharochalasis. The ability of antihistamines, sympathomimetics, steroids, mast cell stabilisers, and cold compresses to improve symptoms of acute attacks has not been determined.

Surgical therapy:

Surgical therapy may be required in quiescent and late stages of the disease.

Surgery is performed after at least six months of disease inactivity. This is performed to correct anatomical defects being produced due to repeated attacks of lid swelling.

Corrective procedures include

  • Repair of dehiscence of levator palpebrae superioris muscle.
  • Eyelid tightening.
  • Blepharoplasty.
  • Reattachment of canthal tendon.
  • Fat grafting for fat atrophy.
  • Reposition of the ectopic and prolapsed lacrimal gland by re-fixation to the orbital rim.
     

Prognosis

The initial onset is usually before the age of 20 years, with unilateral or bilateral swelling of the eyelids and conjunctiva which lasts for hours to several days.

Proptosis indicates orbital involvement. The frequency and severity of repeated episodes tend to lessen with increasing age.

However, unexpected episodes may occur after an extended period of inactivity.

Complications and sequelaes may be

  • Conjunctival oedema.
  • Entropion.
  • Ectropion.
  • Conjunctival redness.
  • Steatoblepharon (sagging of eyelid tissues due to proplapse of fat below the eyelid).
  • Ptosis.
  • Excessively thin skin (cigarette-paper skin).

 

  • PUBLISHED DATE : Jan 23, 2017
  • PUBLISHED BY : DEEPAK CHANDRA
  • CREATED / VALIDATED BY : Dr. S. C. Gupta
  • LAST UPDATED ON : Jan 23, 2017

Discussion

Write your comments

This question is for preventing automated spam submissions
The content on this page has been supervised by the Nodal Officer, Project Director and Assistant Director (Medical) of Centre for Health Informatics. Relevant references are cited on each page.